“Development Of A Box–Behnken Design Optimized Linagliptin Liposphere Formulation For Improved Bioavailability And Sustained Release”. Journal of Carcinogenesis 24, no. 7s (September 30, 2025): 866–877. Accessed December 8, 2025. https://carcinogenesis.com/index.php/JOC/article/view/1187.